tiprankstipranks
Trending News
More News >
Silex Systems Limited (AU:SLX)
:SLX
Advertisement

Silex Systems Limited (SLX) AI Stock Analysis

Compare
51 Followers

Top Page

AU

Silex Systems Limited

(OTC:SLX)

Rating:54Neutral
Price Target:
AU$4.50
▲(5.39%Upside)
Silex Systems Limited's overall score is primarily affected by its financial challenges, particularly in profitability and cash flow consistency. While technical indicators show some positive momentum, the valuation is hindered by a negative P/E ratio, indicating potential overvaluation concerns.

Silex Systems Limited (SLX) vs. iShares MSCI Australia ETF (EWA)

Silex Systems Limited Business Overview & Revenue Model

Company DescriptionSilex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also develops cREO, a semiconductor technology. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.
How the Company Makes MoneySilex Systems Limited generates revenue primarily through the licensing of its laser enrichment technology to commercial partners in the nuclear energy sector. The company's primary revenue stream comes from milestone payments and royalties associated with the commercialization and deployment of its technology by partners, such as the Global Laser Enrichment (GLE) partnership with Cameco and GE Hitachi Nuclear Energy. These partnerships facilitate the scaling and application of Silex's technology, providing a pathway for recurring revenue based on the operational success and adoption of its enrichment solutions. Additionally, Silex may benefit from government grants and research and development incentives, given its focus on advancing nuclear technology.

Silex Systems Limited Financial Statement Overview

Summary
Silex Systems Limited faces several financial challenges, particularly in profitability and cash flow consistency. Despite modest revenue growth and a strong balance sheet, the company reports ongoing operational losses and fluctuating cash flows.
Income Statement
45
Neutral
Silex Systems Limited shows modest revenue growth, but consistent negative profitability indicators such as gross profit margin and net profit margin suggest ongoing operational challenges. The company has faced widening losses, as indicated by negative EBIT and EBITDA margins, impacting its ability to generate consistent earnings.
Balance Sheet
65
Positive
The balance sheet is relatively stable, with a strong equity position and manageable debt levels, reflected in a low debt-to-equity ratio. The high equity ratio indicates a solid capital structure, but the return on equity remains negative due to ongoing losses, suggesting room for improvement in leveraging equity investments to generate profit.
Cash Flow
55
Neutral
Cash flow analysis reveals some improvement, with positive operating cash flow and free cash flow in the latest period. However, historical volatility and negative cash flow in previous periods highlight potential liquidity risks. The free cash flow to net income ratio indicates difficulties in converting revenues into liquid assets, although recent trends are more favorable.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue6.11M6.84M4.22M1.92M1.65M
Gross Profit-5.09M-1.98M-2.86M-4.42M1.29M
EBITDA-22.27M-5.53M-9.00M-6.61M-8.28M
Net Income-22.73M-17.36M-9.46M-6.93M-7.80M
Balance Sheet
Total Assets141.56M152.20M54.12M24.04M29.39M
Cash, Cash Equivalents and Short-Term Investments117.00M140.74M46.53M19.90M26.94M
Total Debt1.18M772.14K982.50K38.40K48.10K
Total Liabilities9.62M3.51M3.57M1.97M1.92M
Stockholders Equity131.94M148.69M50.55M22.07M27.47M
Cash Flow
Free Cash Flow5.85M-2.43M287.28K-4.96M-7.08M
Operating Cash Flow6.14M-2.34M412.64K-4.78M-6.84M
Investing Cash Flow7.56M-114.40M-40.06M9.79M5.16M
Financing Cash Flow2.34M114.55M38.20M-199.34K638.08K

Silex Systems Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4.27
Price Trends
50DMA
3.71
Positive
100DMA
3.61
Positive
200DMA
4.53
Negative
Market Momentum
MACD
0.13
Positive
RSI
58.16
Neutral
STOCH
72.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SLX, the sentiment is Positive. The current price of 4.27 is above the 20-day moving average (MA) of 4.16, above the 50-day MA of 3.71, and below the 200-day MA of 4.53, indicating a neutral trend. The MACD of 0.13 indicates Positive momentum. The RSI at 58.16 is Neutral, neither overbought nor oversold. The STOCH value of 72.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:SLX.

Silex Systems Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AUTYR
76
Outperform
AU$507.52M16.7515.36%7.50%204.66%
AUBVS
66
Neutral
AU$981.90M13.6357.04%2.92%18.63%
AUNXL
62
Neutral
AU$750.76M308.39-0.19%17.64%96.99%
AUSLX
54
Neutral
AU$1.01B-24.29%40.28%-59.83%
AUWIN
51
Neutral
AU$11.00M-118.63%-1123.94%
51
Neutral
AU$1.55B2.02-31.50%3.11%16.21%-7.40%
AUWBT
39
Underperform
AU$421.00M-46.55%905.48%10.02%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:SLX
Silex Systems Limited
4.27
-0.65
-13.21%
AU:WIN
Widgie Nickel Limited
0.02
0.00
0.00%
AU:BVS
Bravura Solutions Limited
2.20
1.17
113.59%
AU:TYR
Tyro Payments Ltd.
0.99
0.03
3.13%
AU:WBT
Weebit Nano Ltd.
2.17
-0.16
-6.87%
AU:NXL
Nuix Ltd.
2.52
-0.79
-23.87%

Silex Systems Limited Corporate Events

GLE Advances Licensing for Paducah Laser Enrichment Facility
Jul 1, 2025

Global Laser Enrichment (GLE), the exclusive licensee of Silex’s uranium enrichment technology, has submitted a comprehensive Safety Analysis Report to the US Nuclear Regulatory Commission for the Paducah Laser Enrichment Facility in Kentucky. This submission marks a crucial step towards obtaining a license to re-enrich depleted uranium tails, potentially establishing a new domestic source of uranium enrichment in the US by 2030. This development positions GLE as a leader in the US nuclear enrichment sector, with the potential to significantly impact nuclear fuel production through the SILEX technology, contingent upon favorable market conditions and industry support.

The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.21 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

State Street Corporation Becomes Substantial Holder in Silex Systems
Jun 25, 2025

Silex Systems Limited has announced that State Street Corporation and its subsidiaries have become substantial holders in the company as of June 23, 2025. This development indicates a significant investment interest from a major financial institution, potentially impacting the company’s market perception and stakeholder confidence.

The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.90 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

VanEck Becomes Substantial Holder in Silex Systems
Jun 24, 2025

Van Eck Associates Corporation (VEAC) has become a substantial holder in Silex Systems Limited, acquiring a 5.39% voting power through its investment management business. This acquisition, involving over 12.8 million ordinary shares, signifies a notable investment in Silex Systems, potentially impacting the company’s market positioning and stakeholder interests in the nuclear energy sector.

The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.90 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Advances Uranium Enrichment Technology with GLE
Jun 5, 2025

Silex Systems Limited announced progress in the commercialization of its SILEX uranium enrichment technology through its joint venture, Global Laser Enrichment (GLE). The company is advancing a large-scale technology demonstration at GLE’s facility in Wilmington, NC, expected to complete by year-end, and is preparing to submit a license application for a commercial plant in Kentucky. The developments align with US government priorities to expand domestic nuclear energy capabilities, potentially benefiting from recent executive orders aimed at strengthening the sector.

The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.46 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Limited to Quote New Securities on ASX
May 21, 2025

Silex Systems Limited has announced the issuance of 3,000 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code SLX. This move is part of the company’s strategic efforts to enhance its financial standing and expand its market presence, potentially impacting its operations and positioning within the industry.

The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.21 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.

Silex Systems Advances Uranium Enrichment Technology with Key US Government Support
May 6, 2025

Silex Systems Limited has announced progress in its SILEX laser-based uranium enrichment technology, with Global Laser Enrichment (GLE) starting TRL-6 demonstration testing in Wilmington, NC. This testing is crucial for validating large-scale enrichment performance and is expected to be completed by the end of 2025. The company is also advancing its manufacturing capabilities to support future technology readiness levels. Additionally, GLE has secured initial funding from the US Department of Energy, marking a significant milestone in its commercialization efforts and potentially paving the way for larger-scale funding to support US energy security.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 15, 2025